Search by Drug Name or NDC
NDC 33342-0055-12 Pioglitazone 30 mg/1 Details
Pioglitazone 30 mg/1
Pioglitazone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is PIOGLITAZONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Pioglitazone is used with a diet and exercise program and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood). Pioglitazone is in a class of medications called thiazolidinediones. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels. Pioglitazone is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated). Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems.Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 33342-0055-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pioglitazone
Product Information
NDC | 33342-0055 |
---|---|
Product ID | 33342-055_7d118937-d5b2-402f-8e24-f70a48c1d432 |
Associated GPIs | 27607050100330 |
GCN Sequence Number | 042944 |
GCN Sequence Number Description | pioglitazone HCl TABLET 30 MG ORAL |
HIC3 | C4N |
HIC3 Description | ANTIHYPERGLYCEMIC,THIAZOLIDINEDIONE(PPARG AGONIST) |
GCN | 93001 |
HICL Sequence Number | 020324 |
HICL Sequence Number Description | PIOGLITAZONE HCL |
Brand/Generic | Generic |
Proprietary Name | Pioglitazone |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Pioglitazone |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 30 |
Active Ingredient Units | mg/1 |
Substance Name | PIOGLITAZONE HYDROCHLORIDE |
Labeler Name | Macleods Pharmaceuticals Limited |
Pharmaceutical Class | PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA202467 |
Listing Certified Through | 2024-12-31 |
Package
NDC 33342-0055-12 (33342005512)
NDC Package Code | 33342-055-12 |
---|---|
Billing NDC | 33342005512 |
Package | 100 TABLET in 1 BOX, UNIT-DOSE (33342-055-12) |
Marketing Start Date | 2013-02-14 |
NDC Exclude Flag | N |
Pricing Information | N/A |